Key Market Indicator:
Ad-hoc news is mandatory information from listed companies that must be made available to investors. Depending on the occasion and content of the news, it can have an impact on the share price. The newsfeed covers a wide range of topics relevant to investor relations and is recommended as an important source of information before making an investment decision.
Tue, 17.06.2025
Fresenius Medical Care AG
Bad Homburg, June 17, 2025 – Fresenius Medical Care AG (“Company”) has decided to conduct a share buyback program with a volume of EUR 1 billion (excluding ancillary costs) in tranches within two years after the start of the program.
The execution of the share buyback program in tranches is planned to commence in the second half of 2025. The share [ … ]
Tue, 17.06.2025
Formycon AG
Disclosure of Inside Information Pursuant to Article 17 of Regulation (EU) No. 596/2014
NOT FOR DISTRIBUTION, PUBLICATION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH DISTRIBUTION OR PUBLICATION MAY BE UNLAWFUL. FURTHER RESTRICTIONS APPLY. PLEASE [ … ]
Mon, 16.06.2025
The Grounds Real Estate Development AG
Ad hoc announcement pursuant to Article 17 of the Market Abuse Regulation
- Management Board negotiating potential takeover of asset management for individual companies of the insolvent Ziegert Group -
Berlin, 16. June 2025 - The Management Board of The Grounds Real Estate Development AG ("Company" / ISIN DE000A40KXL9) is in discussions with t [ … ]
Mon, 16.06.2025
Mister Spex SE
Berlin, 16 June 2025 – The Management Board of Mister Spex SE (the “Company”) today resolved to adjust its revenue guidance for the financial year 2025 based on indicative figures for May 2025 and current trading dynamics.
Persistent market-wide discounting continues to pressure pricing, especially in sunglasses and online sales. As part of its Sp [ … ]
Mon, 16.06.2025
Novem Group S.A.
Novem Group S.A.: Suspension of dividend
Luxembourg, 16 June 2025 – The Management Board of Novem Group S.A., in agreement with the Supervisory Board of the Company, will propose to the Annual General Meeting on 21 August 2025 not to distribute a dividend for the financial year 2024/25.
The suggestion is founded on the frail market development, m [ … ]
Mon, 16.06.2025
Lenzing AG
Intended exchange offer for EUR 500 million undated subordinated resettable fixed rate notes with the ISIN XS2250987356 (Hybrid Bond 2020), including the issue of new Euro-denominated undated subordinated resettable fixed rate notes (Hybrid Bond 2025)
Lenzing – Lenzing Aktiengesellschaft (“Lenzing AG”) intends to announce an exclusive offer to qu [ … ]
Mon, 16.06.2025
CECONOMY AG
The Chairman of the Supervisory Board of CECONOMY AG ("Company"), Mr. Thomas Dannenfeldt, has informed the Company that he intends to resign from his supervisory board mandate for personal reasons at the end of July 2025. Consequently, he will also relinquish his positions as Chairman of the Supervisory Board, the Supervisory Board Presidium, the S [ … ]
Mon, 16.06.2025
SIMONA Aktiengesellschaft
Kirn, 18 June 2025. SIMONA AG plans to acquire 100 percent of the ownership interests in Electroplast B. V. and Dutchclamp B. V., based in Dordrecht, Netherlands. Electroplast is a provider of plastic solutions for the protection of cables and pipes, the focus being on cable protection sheets and ducts. Dutchclamp develops and produces plastic cabl [ … ]
Fri, 13.06.2025
CERDIOS SE
CERDIOS SE: Board of Directors approves acquisition of 9.99% of Activa Asset Management AD
Vaduz, June 13, 2025: CERDIOS SE (ISIN: DE000A3DQFR5) announces that at today's Board of Directors meeting, it was resolved to acquire 9.99% of Activa Asset Management AD, Sofia/Bulgaria by way of a contribution in kind through the issuance of 500,000 new sh [ … ]
Fri, 13.06.2025
APONTIS PHARMA AG
Publication of inside information pursuant to Article 17 of the Regulation (EU) No. 596/2014APONTIS PHARMA AG: Merger Squeeze-out Cash Compensation Determined at EUR 10.40
Monheim / Rhein, 13 June 2025. APONTIS PHARMA AG announces that Zentiva AG submitted a specified request (konkretisiertes Verlangen) to the APONTIS PHARMA AG management board, pu [ … ]